Potency and selectivity of the tachykinin NK 3 receptor antagonist SR142801

By Beaujouan J.-C.   Saffroy M.   Torrens Y.   Glowinski J.  

European Journal of Pharmacology, Vol. 319, Iss. 2, 1997-01 ,pp. : 307-316

Elsevier

Access to resources Recommend Favorite

Inhibition of inflammatory cell recruitment by the tachykinin NK 3 -receptor antagonist, SR 142801, in a murine model of asthma

By Nenan S.   Germain N.   Lagente V.   Emonds-Alt X.   Advenier C.   Boichot E.  

European Journal of Pharmacology, Vol. 421, Iss. 3, 2001-06 ,pp. : 201-205

Elsevier

Access to resources Recommend Favorite

Peripheral tachykinin receptors as targets for new drugs

By Patacchini R.   Maggi C.A.  

European Journal of Pharmacology, Vol. 429, Iss. 1, 2001-10 ,pp. : 13-21

Elsevier

Access to resources Recommend Favorite

Tachykinins and Tachykinin Receptors: Structure and Activity Relationships

By  

Current Medicinal Chemistry, Vol. 11, Iss. 15, 2004-08 ,pp. : 2045-2081

Bentham Science Publishers

Access to resources Recommend Favorite

Peripheral tachykinin receptors as potential therapeutic targets in visceral diseases

By Lecci Alessandro   Maggi Carlo Alberto  

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 3, 2003-06 ,pp. : 343-362

Informa Healthcare

Access to resources Recommend Favorite